Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Effects of analogue insulin in multiple daily injection therapy of type 2 diabetes on postprandial glucose control and cardiac function compared to human insulin: a randomized controlled long-term study.

von Bibra H, Siegmund T, Kingreen I, Riemer M, Schuster T, Schumm-Draeger PM.

Cardiovasc Diabetol. 2016 Jan 16;15:7. doi: 10.1186/s12933-015-0320-2.

2.

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.

Hermansen K, Bohl M, Schioldan AG.

Drugs. 2016 Jan;76(1):41-74. doi: 10.1007/s40265-015-0500-0. Review.

3.

Number-Based Approach to Insulin Taxonomy.

Kalra S, Gupta Y.

Diabetes Ther. 2015 Dec;6(4):469-479. Epub 2015 Sep 9.

4.

Immunological hypoglycemia associated with insulin antibodies induced by exogenous insulin in 11 Chinese patients with diabetes.

Quan H, Tan H, Li Q, Li J, Li S.

J Diabetes Res. 2015;2015:746271. doi: 10.1155/2015/746271. Epub 2015 Apr 15.

5.

Advances in management of type 1 diabetes mellitus.

Aathira R, Jain V.

World J Diabetes. 2014 Oct 15;5(5):689-96. doi: 10.4239/wjd.v5.i5.689. Review.

6.

Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.

Arai K, Takai M, Hirao K, Matsuba I, Matoba K, Takeda H, Kanamori A, Yamauchi M, Mori H, Terauchi Y.

J Diabetes Investig. 2012 Aug 20;3(4):396-401. doi: 10.1111/j.2040-1124.2012.00198.x.

7.

Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus.

Heller S, Bode B, Kozlovski P, Svendsen AL.

J Diabetes. 2013 Dec;5(4):482-91. doi: 10.1111/1753-0407.12060. Epub 2013 May 7.

8.

Intrinsic fibrillation of fast-acting insulin analogs.

Woods RJ, Alarcón J, McVey E, Pettis RJ.

J Diabetes Sci Technol. 2012 Mar 1;6(2):265-76.

9.

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations.

Uy J, Fogelfeld L, Guerra Y.

Diabetes Metab Syndr Obes. 2012;5:1-10. doi: 10.2147/DMSO.S15404. Epub 2012 Jan 10.

10.

Superior efficacy of new medicines?

van Luijn JC, Gribnau FW, Leufkens HG.

Eur J Clin Pharmacol. 2010 May;66(5):445-8. doi: 10.1007/s00228-010-0808-3. Epub 2010 Mar 12.

11.
12.

Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.

Heller S, Damm P, Mersebach H, Skjøth TV, Kaaja R, Hod M, Durán-García S, McCance D, Mathiesen ER.

Diabetes Care. 2010 Mar;33(3):473-7. doi: 10.2337/dc09-1605. Epub 2009 Dec 10.

13.

An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.

Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ.

Diabet Med. 2009 Aug;26(8):803-14. doi: 10.1111/j.1464-5491.2009.02775.x. Review.

14.

Continuous subcutaneous insulin infusion versus multiple daily injections.

Karagianni P, Sampanis Ch, Katsoulis Ch, Miserlis G, Polyzos S, Zografou I, Stergiopoulos S, Douloumbakas I, Zamboulis Ch.

Hippokratia. 2009 Apr;13(2):93-6.

15.

Use of short-acting insulin aspart in managing older people with diabetes.

Marouf E, Sinclair AJ.

Clin Interv Aging. 2009;4:187-90. Epub 2009 May 14. Review.

16.

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.

Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H.

CMAJ. 2009 Feb 17;180(4):385-97. doi: 10.1503/cmaj.081041.

17.
18.
19.

Insulin pumps are still debatable for type 1 diabetes.

DeVries JH, Heine RJ.

BMJ. 2002 Jul 6;325(7354):46. No abstract available.

Supplemental Content

Support Center